Thu, April 18, 2024
Wed, April 17, 2024
Tue, April 16, 2024
Mon, April 15, 2024

David Risinger Initiated (ANAB) at Buy and Held Target at $47 on, Apr 16th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-47-on-apr-16th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Risinger of Leerink Partners, Initiated "AnaptysBio, Inc." (ANAB) at Buy and Held Target at $47 on, Apr 16th, 2024.

David has made no other calls on ANAB in the last 4 months.



There are 6 other peers that have a rating on ANAB. Out of the 6 peers that are also analyzing ANAB, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Anupam Rama of "JP Morgan" Maintained at Hold with Decreased Target to $28 on, Monday, April 1st, 2024


These are the ratings of the 5 analyists that currently disagree with David


  • Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $56 on, Thursday, April 11th, 2024
  • David Nierengarten of "Wedbush" Upgraded from Hold to Buy and Increased Target to $34 on, Tuesday, March 12th, 2024
  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $55 on, Monday, February 26th, 2024
  • Alex Schwartz of "Stifel" Initiated at Strong Buy and Held Target at $50 on, Wednesday, February 21st, 2024
  • Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $80 on, Friday, February 16th, 2024

Publication Contributing Sources